1)Fujimura M, et al;Research Committee on Moyamoya Disease(Spontaneous Occlusion of Circle of Willis)of the Ministry of Health, Labor Welfare, Japan;Guideline Committee 2021 of the Japan Stroke Society:2021 Japanese guidelines for the management of moyamoya disease:guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir(Tokyo)62:165-170, 2022
2)Kuroda S, et al;Research Committee on Moyamoya Disease(Spontaneous Occlusion of Circle of Willis)of the Ministry of Health, Labor, and Welfare, Japan:Diagnostic criteria for moyamoya disease - 2021 revised version. Neurol Med Chir(Tokyo)62:307-312, 2022
3)冨永悌二,他:もやもや病(ウイリス動脈輪閉塞症)診断・治療ガイドライン(改訂版).脳卒中の外 46:1-24, 2018
4)黒田 敏,他:もやもや病診断基準—2021年改訂版.脳卒中の外 50:1-7, 2022
5)Kurokawa T, et al:Prognosis of occlusive disease of the circle of Willis(moyamoya disease)in children. Pediatr Neurol 1:274-277, 1985
6)Hayashi T, et al:Preoperative risks of cerebral infarction in pediatric moyamoya disease. Stroke 52:2302-2310, 2021
7)Karasawa J, et al:Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 77:84-89, 1992
8)日本脳卒中学会,他:アセタゾラミド(ダイアモックス注射用)適正使用指針.2015 https://www.jsts.gr.jp/img/acetazolamide.pdf(2022年6月24日アクセス)
9)Yokosawa M, et al:Efficacy of superficial temporal artery-middle cerebral artery double anastomoses in a patient with rapidly progressive moyamoya disease:case report. Neurol Med Chir(Tokyo)54:836-840, 2014
10)Hayashi T, et al:Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease:the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure:technical case report. Neurosurgery 64:E195-E196;discussion E196, 2009 doi:10.1227/01.NEU.0000336311.60660.26
11)Kimiwada T, et al:Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease. J Neurosurg Pediatr 21:632-638, 2018